Do Weight-Loss Drugs Like Wegovy Steal Your Muscle?
When you lose weight, some of it always comes from muscle, not just fat. This is true for any diet, and it is also true for GLP-1 medicines such as semaglutide (Wegovy) and tirzepatide (Zepbound). In the STEP 1 trial of semaglutide, about 40% of the total weight people lost was fat-free mass, a category that includes muscle. That number sounds alarming, but it needs context.
The context: even though absolute muscle dropped, fat dropped much more, so the proportion of muscle in the body actually went up and overall body composition improved. A 2026 study in Cell Reports Medicine found that weight loss with GLP-1 medicines did not cause a disproportionate loss of muscle mass or function in obese mice and humans; fat and liver shrank faster than skeletal muscle, and grip and leg strength held steady in a small human group.
At the 2026 American Diabetes Association meeting, researchers reported that newer GLP-1 based therapies are being designed to protect muscle even better. Still, losing some lean tissue matters most for older adults and anyone at risk of frailty or weakness.
Practical steps: strength or resistance training 2-3 times a week and eating enough protein (about 1.2 to 1.6 grams per kilogram of body weight per day) help preserve or even build muscle while you lose fat. Talk to your doctor or a dietitian about a plan that fits you. This is general information, not medical advice.